Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2007

View Archived Issues

Assessing the efficacy of new drugs for multiple sclerosis in clinical trials: II

Novel therapeutic options for metabolic disorders described in recent patents

Atorvastatin may increase multiple sclerosis activity

Novel therapeutic agents for respiratory disorders described in recent patents

UK-371804: a novel selective urokinase-type plasminogen activator inhibitor from Pfizer

Plant-produced smallpox subunit vaccine protects mice against lethal vaccinia virus challenge

ABS-75: a novel fullerene derivative with neuroprotective activity in vivo

GenVec obtains additional funding for malaria vaccine program

In vivo imaging of primate brain with novel adenosine A2 receptor radioligand

AL-39324 reduces ocular angiogenesis in different animal models in vivo

Sunesis earns preclinical milestone payment in BACE collaboration with Merck

Nucleonics cleared for phase I study of eiRNA therapy for chronic HBV

AVI and Ercole collaborate in DMD and beta thalassemia

RegeneRx cleared to begin cardiovascular program for Tbeta4

Positive findings from preclinical testing of caprospinol

Array begins phase I cancer study for ARRY-520

Enrollment completed in phase II study of MBP-8298 for relapsing-remitting MS

Novavax obtains positive results for pandemic influenza vaccine in ferrets

AeroLEF shows statistically significant difference in SPRID4 in postoperative pain

Immunotherapy with MHC II-expressing tumor cells may be useful in uveal melanoma

New antithrombotic agents disclosed in recent sanofi-aventis Deutschland patent

SR Pharma changes name to Silence Therapeutics

Spectrum cleared to add Canadian sites to BPH program for ozarelix

Chugai elects to copromote Actemra in France, Germany and U.K

FDA approves new indication for Fragmin

Approvable letter for CIP-Tramadol ER

Fast track designation for pixantrone in relapsed or refractory NHL

Abbott seeks U.S. and E.U. approvals for Humira in juvenile rheumatoid arthritis

Pylera launched for eradication of H. pylori

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...